Back
NovaBay Pharmaceuticals, Inc. Vs. Expedia Group, Inc. Industry Stock Comparison
Sell
31
NBY
NovaBay Pharmaceuticals, Inc.
Last Price:
$1.97
Seasonality Move:
-11.11%
Buy
54
EXPE
Expedia Group, Inc.
Last Price:
$225.29
Seasonality Move:
14.07%
Sell
31
NovaBay Pharmaceuticals, Inc. (NBY)
is a Sell
Is NovaBay Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current NovaBay Pharmaceuticals, Inc. [NBY] share price is $1.95. The Score for NBY is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
NBY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Expedia Group, Inc. (EXPE)
is a Buy
Is Expedia Group, Inc. a Buy, Sell or Hold?
-
The current Expedia Group, Inc. [EXPE] share price is $225.30. The Score for EXPE is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
EXPE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals, Inc.'s stock price today?
-
The NovaBay Pharmaceuticals, Inc. share price today is $1.95Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
EXPE Stock Price Chart
What is Expedia Group, Inc.'s stock price today?
-
The Expedia Group, Inc. share price today is $225.30Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EXPE is experiencing slight buying pressure.
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.43 | Buy |
| Relative Strength Index (14 RSI): | 42.51 | Sell |
| Chaikin Money Flow: | 531980 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.24 - 1.56) | Buy |
| Bollinger Bands (100): | (-5.24 - 31.74) | Sell |
EXPE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.18 | Sell |
| Relative Strength Index (14 RSI): | 44.34 | Sell |
| Chaikin Money Flow: | 196328 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (222.25 - 241.17) | Sell |
| Bollinger Bands (100): | (225.55 - 281.55) | Sell |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.54 | Buy |
| 20-day SMA: | 1.39 | Buy |
| 50-day SMA: | 4.04 | Sell |
| 200-day SMA: | 9.63 | Sell |
| 8-day EMA: | 1.5 | Buy |
| 20-day EMA: | 1.05 | Buy |
| 50-day EMA: | 0.56 | Buy |
| 200-day EMA: | 0.16 | Buy |
EXPE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 230.28 | Sell |
| 20-day SMA: | 233.77 | Sell |
| 50-day SMA: | 233.32 | Sell |
| 200-day SMA: | 227.99 | Sell |
| 8-day EMA: | 229.48 | Sell |
| 20-day EMA: | 230.87 | Sell |
| 50-day EMA: | 236.27 | Sell |
| 200-day EMA: | 227.56 | Sell |
NovaBay Pharmaceuticals, Inc. Earnings Growth & NBY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and a decrease next year of $0.00 per share.
Expedia Group, Inc. Earnings Growth & EXPE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.65 per share, a decrease next quarter of $6.88 per share, an increase this year of $4.01 per share, and an increase next year of $3.61 per share.
NovaBay Pharmaceuticals, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Expedia Group, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||